Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D12217 Imlunestrant tosylate (USAN); Imlunestrant tosilate (JAN)
Drug groups [BR:br08330]
Antineoplastic
DG01585 Estrogen receptor antagonist
DG03177 Imlunestrant
D12217 Imlunestrant tosylate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03177 Imlunestrant
D12217 Imlunestrant tosylate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03177 Imlunestrant
D12217 Imlunestrant tosylate
DG03184 UGT1A3 substrate
DG03177 Imlunestrant
D12217 Imlunestrant tosylate
DG03186 UGT1A8 substrate
DG03177 Imlunestrant
D12217 Imlunestrant tosylate
DG03188 UGT1A9 substrate
DG03177 Imlunestrant
D12217 Imlunestrant tosylate
DG03375 UGT1A10 substrate
DG03177 Imlunestrant
D12217 Imlunestrant tosylate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
Estrogen receptor
NR3A1 (ESR1)
D12217 Imlunestrant tosylate (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12217
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12217
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12217
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12217
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D12217
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D12217
Drug groups [BR:br08330]
Antineoplastic
DG01585 Estrogen receptor antagonist
DG03177 Imlunestrant
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03177 Imlunestrant
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03177 Imlunestrant
DG03184 UGT1A3 substrate
DG03177 Imlunestrant
DG03186 UGT1A8 substrate
DG03177 Imlunestrant
DG03188 UGT1A9 substrate
DG03177 Imlunestrant
DG03375 UGT1A10 substrate
DG03177 Imlunestrant